NCT01604733View on ClinicalTrials.gov

Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Hypercholesterolemia
Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT01604733 - Centralized Pan-Middle East Survey on the Undertreatment of Hypercholesterolemia | Biotech Hunter | Biotech Hunter